Middle East and Africa Warts Therapeutics Market

Market Introduction

Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

Thus, the new product developments are expected to create a significant demand for warts therapeutics in the coming years, which is further anticipated to drive the warts therapeutics market.

Since the beginning of 2020, the COVID-19 pandemic has caused enormous health, social and economic impacts, likely to continue in 2021. Even after some of these impacts have been mitigated or contained, there will be medium and longer-term consequences. The pandemic has caused disruptions to health services worldwide and has impacted the ability of countries to address and respond STIs. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures, and Iran was in a deep economic recession due to the US sanctions. In many countries, STI services have been disrupted, and supply chains for key commodities have been stretched. In Africa, COVID-19 has threatened the control of major high-burden diseases such as HIV, and other STIs. As COVID-19 continues to spread in Africa, there are concerns over its impact on women and girls, limited testing, and decreased access to expert STI clinical further fueling an STI epidemic that is driven by health disparities, particularly among marginalized populations.

Middle East and Africa Warts Therapeutics Strategic Insights

Strategic insights for the Middle East and Africa Warts Therapeutics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Warts Therapeutics Report Scope

Middle East and Africa Warts Therapeutics Regional Insights

The geographic scope of the Middle East and Africa Warts Therapeutics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Warts therapeutics market in Middle East and Africa is expected to grow from US$ 81.6 million in 2021 to US$ 96.6 million by 2028; it is estimated to grow at a CAGR of 2.4% from 2021 to 2028. The rising prevalence of warts is encouraging companies in the life sciences industry to focus on research and development of new drugs for warts treatment. There is a continuous need for new, innovative therapeutic approaches for better treatment outcomes. Despite being common, many topical therapeutics require multiple administrations, and they can be ineffective in recurrence. To overcome this challenge, Cassiopea is developing CB-06-02, an NCE immune modulator, to treat genital warts. This a low toxicity immunomodulator supporting the natural immune response against HPV is currently in phase II clinical trial. Based on the drug profiling to date, the CB-06-02 is expected to exhibit a faster action and a lower recurrence rate than the existing treatments. Thus, the growing pipeline of wart therapeutics is a prime force boosting the market growth.

Key Market Segments

In terms of type, the common warts segment accounted for the largest share of the Middle East and Africa warts therapeutics market in 2020. In terms of treatment, the physical destruction segment accounted for the largest share of the Middle East and Africa warts therapeutics market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Middle East and Africa warts therapeutics market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the warts therapeutics market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bausch Health Companies Inc., Euro Vital Pharma GmbH, Cipla Inc., Koninklijke Utermöhlen NV, Scholl's Wellness Company, Teva Pharmaceutical Industries Ltd, and GlaxoSmithKline plc.

Reasons to buy report

• To understand the Middle East and Africa Warts therapeutics market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa Warts therapeutics market
• Efficiently plan M&A and partnership deals in Middle East and Africa Warts therapeutics market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa Warts therapeutics market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East and Africa region.

MIDDLE EAST AND AFRICA WARTS THERAPEUTICS MARKET SEGMENTATION

By Type

• Common Warts
• Genital Warts
• Flat Warts
• Others

By Treatment

• Physical Destruction

• Cryotherapy
• Surgical Removal
• Laser Treatment

• Immunomodulation

• Interferons
• Retinoids
• Zinc

• Chemical Destruction

• Bleomycin
• Cantharidin
• Salicylic Acid
• Others

By End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

By Country

• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Companies Mentioned

1. Bausch Health Companies Inc.           
2. Euro Vital Pharma GmbH                 
3. Cipla Inc.                 
4. Koninklijke Utermöhlen NV                 
5. Scholl's Wellness Company             
6. Teva Pharmaceutical Industries Ltd                  
7. GlaxoSmithKline plc.